期刊文献+

鼻咽癌调强放疗过程中剂量变化的分析 被引量:1

Dose variation in the course of IMRT treatment to nasopharyngeal carcinoma
下载PDF
导出
摘要 目的研究鼻咽癌调强放疗(IMRT)中计划与初始计划的差异及其可能的相关因素。方法 13例行根治性IMRT的鼻咽癌患者在放疗第21次时行螺旋CT扫描,以热塑面膜上的3个激光定位标记点作为参考标记,将首次治疗计划复制到新CT图像上,利用调强计划系统进行正向计算,得到原计划在第21次时的实际剂量分布,并与初始计划进行比较。结果治疗第21次时,腮腺体积均有减小,左侧减少(10.53±6.73)cm3(t=5.637,P=0.000),右侧减少(10.49±11.31)cm3(t=3.345,P=0.006);左腮腺V26为(2.20±2.64)%(t=3.016,P=0.011),右腮腺V26为(2.13±2.96)%(t=2.596,P=0.023),而双侧平均剂量Dmean与V(50Gy)无统计学意义。脑干Dmax为(3.18±5.56)Gy(t=2.066,P=0.061),脑干D1cc为(4.00±5.30)Gy(t=2.723,P=0.019)),脑干D1%为(4.22±6.27)Gy(t=2.426,P=0.032)。脊髓D0.1cc为(7.59±6.90)Gy(t=3.969,P=0.002),脊髓D1cc为(3.96±3.95)Gy(t=3.618,P=0.004),脊髓Dmax为(8.49±6.01)Gy(t=5.094,P=0.000),脊髓Dmean为(2.05±2.79)Gy(t=2.657,P=0.021)。靶区Dmax为(1.12±2.54)Gy(t=1.583,P=0.139),靶区Dmin为(2.72±6.51)Gy(t=1.509,P=0.157),靶区Dmean为(0.12±0.49)Gy(t=0.908,P=0.382)。此外,垂体、晶体、眼球、颞叶剂量等均无显著意义。在分析剂量变化与体重、T分期、N分期、位置变化(以齿状突为参考点)的研究中,仅显示T分期影响脑干的Dmax值(r=0.561,P=0.046),其余均无明显相关。结论鼻咽癌调强放疗中,虽然靶区的剂量变化不大,但是脑干和脊髓的剂量增高明显,差异较大,因此在临床上治疗过程中有必要再次CT重新勾画计算,以保护脑干和脊髓。 Objective To analyze the variation of dose during the IMRT for nasopharyngeal carcinoma(NPC),and try to find out the influencing factor.Methods Thirteen NPC patients treated with definitive IMRT.Computed tomography plan were acquired,including the first scan for primary plan and the second scan in the fifth week(the twenty first fraction) for the second plan.Same parameter of primary plan were set to the second CT with the help of the three points on mask,then the dose distribution in the newer CT was calculated.Results During the treatment,volume of parotid gland decreased,the left was(10.53±6.73)cm3(t=5.637,P=0.000),the right was(10.49±11.31) cm3(t=3.345,P=0.006);V26 of the left parotid was(2.20±2.64)%(t=3.016,P=0.011),the right was(2.13±2.96)%(t=2.596,P=0.023),meanwhile there was no statistic difference in Dmean,V(50Gy).Brain stem Dmax was(3.18±5.56)Gy(t=2.066,P=0.061),D1cc was(4.00±5.30) Gy(t=2.723,P=0.019),D1% was(4.22±6.27)Gy(t=2.426,P=0.032).Spinal cord D0.1cc was(7.59±6.90)Gy(t=3.969,P=0.002),D1cc was(3.96±3.95)Gy(t=3.618,P=0.004),Dmax was(8.49±6.01)Gy(t=5.094,P=0.000),Dmean was(2.05±2.79)Gy(t=2.657,P=0.021).Target volume Dmax was(1.12±2.54)Gy(t=1.583,P=0.139),Dmean was(2.72±6.51)Gy(t=1.509,P=0.157),Dmean was(0.12±0.49)Gy(t=0.908,P=0.382).But no statistic difference were found in dose variation of pituitary,lens,eyeball,temple robe.Only T stage in all the variations such as weight loss,shrinked tumor volume affected the brainstem Dmax with statistical significance.Conclusion Repeated CT scan among the IMRT course is necessary for protecting brainstem and spinal cord,because the obvious dose was raising of brainstem and spinal cord,despite of the minimal variation of target volume.
出处 《临床肿瘤学杂志》 CAS 2011年第7期626-629,共4页 Chinese Clinical Oncology
关键词 鼻咽肿瘤 调强放疗 剂量变化 Nasopharyngeal carcinoma Intensity modulated radiotherapy(IMRT) Dose variation
  • 相关文献

参考文献5

二级参考文献30

  • 1赵充,卢泰祥,韩非,卢丽霞,黄劭敏,邓小武,林承光,崔念基.139例鼻咽癌调强放疗的临床研究[J].中华放射肿瘤学杂志,2006,15(1):1-6. 被引量:154
  • 2罗京伟,傅卫华,阎蒂,吴秋文,徐国镇,高黎.头颈部癌调强放疗过程中腮腺及靶区体积变化的临床分析[J].中华放射肿瘤学杂志,2006,15(2):129-132. 被引量:33
  • 3曹建忠,罗京伟,徐国镇,高黎,章众,肖建平,黄晓东.鼻咽癌调强放疗中靶区和正常器官变化规律及临床意义探讨[J].中华放射肿瘤学杂志,2007,16(2):81-85. 被引量:53
  • 4Parliament MB, Scrimger RA, Anderson SG, et al. Preservation of oral health related quality of life and salivary flow rates after inverse planned IMRT for head and neck cancer. Int J Radiat Oncol Biol Phys,2004,58: 663-673.
  • 5Lee N, Xia P, Quivey JM, et al. Intensitymodulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys ,2002,53 : 12-22.
  • 6Barker JL, Garden AS, Ang KK, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head and neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys,2004,59: 960-970.
  • 7Elzbieta SK, Ilona B, Borowska I, et al. Changes in lateral dimensions of irradiated volume and their impact on the accuracy of dose delivery during radiotherapy for head and neck cancer. Radiother Oncol,2006,79 : 304-309.
  • 8Eric K, Hansen M, Jeanne M, et al. Repeat CT imaging and replanning during the course of IMRT for head and neck cancer. Int J Radiat Oncol Biol Phys,2006,64: 355-362.
  • 9Hansen EK, Bucci MK, Quivey JM, et al. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys, 2006,64 (2) : 355-362.
  • 10Lee N, Xia P, Quiney JM, et al, Intensity-modulated radiotherapy in the treatment of nasophanyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys, 2002,53 ( 1 ) : 12-22.

共引文献76

同被引文献26

  • 1Zhang X, Li M, Can J, et al. Dosimetric variations of target vol- umes and organs at risk in nasopharyngeal carcinoma intensity- modulated radiotherapy [ J ]. Br J Radiol, 2012,85 ( 1016 ) : e506- 513. DOI : 10. 1259/bjr/20695672.
  • 2Chen C, Fei Z, Chen L, et al. Will weight loss cause significant dosimetric changes of target volumes and organs at risk in nasopha- ryngeal carcinoma treated with intensity-modulated radiation thera- py? [J]. Med Dosim, 2014,39 ( 1 ) : 34-37. DOI: 10. 1016/j. meddos. 2013.09. 002.
  • 3Wang RH, Zhang SX, Zhou LH, et al. Volume and dosimetric variations during two-phase adaptive intensity-modulated radiother- apy for locally advanced nasopharyngeal carcinoma [ J ]. Biomed Mater Eng, 2014, 24 ( 1 ) : 1217-1225. DOI: 10. 3233/BME- 130923.
  • 4Yang H, Hu W, Ding W, et al. Changes of the transverse diame- ter and volume and dosimetry before the 25th fraction during the course of intensity-modulated radiation therapy (IMRT) for pa- tients with nasopharyngeal carcinoma [ J ]. Med Dosim, 2012,37 (2) :225-229. DOI:10. 1016/j. meddos. 2011.08.003.
  • 5Hansen EK, Bucci MK, Quivey JM, et al. Repeat CT imaging and replanning during the course of IMRT for head-and-neck canc- er [ J ]. Int J Radiat Oncol Biol Phys ,2006,64 (2) :355-362.
  • 6Wang W,Yang H, I-Iu W, et al. Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma [J]. Int J Radiat Oncol Biol Phys,2010,77(2) :617-621. DOI: 10. 1016/j. ijrobp. 2009.08. 036.
  • 7Wang X, Lu J, Xiong X, et al. Anatomic and dosimetric changes during the treatment course of intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma [J]. Med Dosim, 2010,35 (2) : 151-157. DO1 : 10. 1016/j. meddos. 2009.06. 007.
  • 8Zhao L, Wan Q, Zhou Y, et al. The role of replanning in fraction- ated intensity modulated radiotherapy for nasopharyngeal carcinoma [J]. Radiother Oncol,2011,98 ( 1 ) :23-27. DOI: 10. 1016/j. ra- donc. 2010.10. 009.
  • 9Cheng HC, Wu VW, Ngan RK, et al. A prospective study on vol- umetric and dosimetric changes during intensity-modulated radio- therapy for nasopharyngeal carcinoma patients [ J ]. Radiother On- col,2012,104 ( 3 ) : 317-323. DOI : 10. 1016/j. radonc. 2012.03. 013.
  • 10Lu J, Ma Y, Chen J, et al. Assessment of anatomical and dosime- tric changes by a deformable registration method during the course of intensity-modulated radiotherapy for nasopharyngeal carcinoma [ J]. J Radiat Res, 2014,55 (2) : 97-104. DOI: 10. 1093/jrr/ rrt076.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部